Industry: Healthcare
Published Date: November-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 193
Report ID: PMRREP28351
1. Executive Summary
1.1. Global Single Domain Antibody Platforms Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global GDP Growth Outlook
2.3.2. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Platforms Type Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter’s Five Force Analysis
4. Global Single Domain Antibody Platforms Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
4.1. Global Single Domain Antibody Platforms Market Outlook: Platforms Type
4.1.1. Introduction / Key Findings
4.1.2. Historical Market Size (US$ Mn) Analysis, By Platforms Type, 2019 - 2022
4.1.3. Current Market Size (US$ Mn) Analysis and Forecast, By Platforms Type, 2023 - 2031
4.1.3.1. Multi-specific
4.1.3.2. Bispecific
4.1.3.3. Multivalent
4.1.3.4. Mono-specific
4.2. Market Attractiveness Analysis: Platforms Type
4.3. Global Single Domain Antibody Platforms Market Outlook: Animal Source
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Mn) Analysis, By Animal Source, 2019 - 2022
4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Source, 2023 - 2031
4.3.3.1. Camelids
4.3.3.1.1. Camels
4.3.3.1.2. Llama
4.3.3.1.3. Alpacas
4.3.3.2. Sharks
4.4. Market Attractiveness Analysis: Animal Source
4.5. Global Single Domain Antibody Platforms Market Outlook: Application
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019 - 2022
4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031
4.5.3.1. Diagnostic Laboratories
4.5.3.2. Therapeutic Development
4.5.3.3. Research and Development Activities
4.6. Market Attractiveness Analysis: Application
4.7. Global Single Domain Antibody Platforms Market Outlook: End User
4.7.1. Introduction / Key Findings
4.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019 - 2022
4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
4.7.3.1. Diagnostic Laboratories
4.7.3.2. Clinical Laboratories
4.7.3.3. Academic and Research Institutes
4.7.3.4. Pharmaceutical and Biotechnology Companies
4.8. Market Attractiveness Analysis: End User
5. Global Single Domain Antibody Platforms Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2022
5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 - 2031
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Single Domain Antibody Platforms Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
6.3.1. By Country
6.3.2. By Platforms Type
6.3.3. By Animal Source
6.3.4. By Application
6.3.5. By End User
6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
6.4.1. U.S.
6.4.2. Canada
6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Platforms Type, 2023 - 2031
6.5.1. Multi-specific
6.5.2. Bispecific
6.5.3. Multivalent
6.5.4. Mono-specific
6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Source, 2023 - 2031
6.6.1. Camelids
6.6.1.1. Camels
6.6.1.2. Llama
6.6.1.3. Alpacas
6.6.2. Sharks
6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031
6.7.1. Diagnostic Laboratories
6.7.2. Therapeutic Development
6.7.3. Research and Development Activities
6.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
6.8.1. Diagnostic Laboratories
6.8.2. Clinical Laboratories
6.8.3. Academic and Research Institutes
6.8.4. Pharmaceutical and Biotechnology Companies
6.9. Market Attractiveness Analysis
7. Europe Single Domain Antibody Platforms Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
7.3.1. By Country
7.3.2. By Platforms Type
7.3.3. By Animal Source
7.3.4. By Application
7.3.5. By End User
7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
7.4.1. Germany
7.4.2. France
7.4.3. U.K.
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Türkiye
7.4.8. Rest of Europe
7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Platforms Type, 2023 - 2031
7.5.1. Multi-specific
7.5.2. Bispecific
7.5.3. Multivalent
7.5.4. Mono-specific
7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Source, 2023 - 2031
7.6.1. Camelids
7.6.1.1. Camels
7.6.1.2. Llama
7.6.1.3. Alpacas
7.6.2. Sharks
7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031
7.7.1. Diagnostic Laboratories
7.7.2. Therapeutic Development
7.7.3. Research and Development Activities
7.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
7.8.1. Diagnostic Laboratories
7.8.2. Clinical Laboratories
7.8.3. Academic and Research Institutes
7.8.4. Pharmaceutical and Biotechnology Companies
7.9. Market Attractiveness Analysis
8. East Asia Single Domain Antibody Platforms Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
8.3.1. By Country
8.3.2. By Platforms Type
8.3.3. By Animal Source
8.3.4. By Application
8.3.5. By End User
8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
8.4.1. China
8.4.2. Japan
8.4.3. South Korea
8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Platforms Type, 2023 - 2031
8.5.1. Multi-specific Single Domain Antibody
8.5.2. Bispecific Single Domain Antibody
8.5.3. Multivalent Single Domain Antibody
8.5.4. Mono-specific Single Domain Antibody
8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Source, 2023 - 2031
8.6.1. Camelids
8.6.1.1. Camels
8.6.1.2. Llama
8.6.1.3. Alpacas
8.6.2. Sharks
8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031
8.7.1. Diagnostic Laboratories
8.7.2. Therapeutic Development
8.7.3. Research and Development Activities
8.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
8.8.1. Diagnostic Laboratories
8.8.2. Clinical Laboratories
8.8.3. Academic and Research Institutes
8.8.4. Pharmaceutical and Biotechnology Companies
8.9. Market Attractiveness Analysis
9. South Asia & Oceania Single Domain Antibody Platforms Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
9.3.1. By Country
9.3.2. By Platforms Type
9.3.3. By Animal Source
9.3.4. By Application
9.3.5. By End User
9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
9.4.1. India
9.4.2. Southeast Asia
9.4.3. ANZ
9.4.4. Rest of South Asia & Oceania
9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Platforms Type, 2023 - 2031
9.5.1. Multi-specific Single Domain Antibody
9.5.2. Bispecific Single Domain Antibody
9.5.3. Multivalent Single Domain Antibody
9.5.4. Mono-specific Single Domain Antibody
9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Source, 2023 - 2031
9.6.1. Camelids
9.6.1.1. Camels
9.6.1.2. Llama
9.6.1.3. Alpacas
9.6.2. Sharks
9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031
9.7.1. Diagnostic Laboratories
9.7.2. Therapeutic Development
9.7.3. Research and Development Activities
9.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
9.8.1. Diagnostic Laboratories
9.8.2. Clinical Laboratories
9.8.3. Academic and Research Institutes
9.8.4. Pharmaceutical and Biotechnology Companies
9.9. Market Attractiveness Analysis
10. Latin America Single Domain Antibody Platforms Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
10.3.1. By Country
10.3.2. By Platforms Type
10.3.3. By Animal Source
10.3.4. By Application
10.3.5. By End User
10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Rest of Latin America
10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Platforms Type, 2023 - 2031
10.5.1. Multi-specific Single Domain Antibody
10.5.2. Bispecific Single Domain Antibody
10.5.3. Multivalent Single Domain Antibody
10.5.4. Mono-specific Single Domain Antibody
10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Source, 2023 - 2031
10.6.1. Camelids
10.6.1.1. Camels
10.6.1.2. Llama
10.6.1.3. Alpacas
10.6.2. Sharks
10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031
10.7.1. Diagnostic Laboratories
10.7.2. Therapeutic Development
10.7.3. Research and Development Activities
10.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
10.8.1. Diagnostic Laboratories
10.8.2. Clinical Laboratories
10.8.3. Academic and Research Institutes
10.8.4. Pharmaceutical and Biotechnology Companies
10.9. Market Attractiveness Analysis
11. Middle East & Africa Single Domain Antibody Platforms Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
11.1. Key Highlights
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2022
11.3.1. By Country
11.3.2. By Platforms Type
11.3.3. By Animal Source
11.3.4. By Application
11.3.5. By End User
11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
11.4.1. GCC Countries
11.4.2. Egypt
11.4.3. South Africa
11.4.4. Northern Africa
11.4.5. Rest of Middle East & Africa
11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Platforms Type, 2023 - 2031
11.5.1. Multi-specific
11.5.2. Bispecific
11.5.3. Multivalent
11.5.4. Mono-specific
11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Source, 2023 - 2031
11.6.1. Camelids
11.6.1.1. Camels
11.6.1.2. Llama
11.6.1.3. Alpacas
11.6.2. Sharks
11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031
11.7.1. Diagnostic Laboratories
11.7.2. Therapeutic Development
11.7.3. Research and Development Activities
11.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
11.8.1. Diagnostic Laboratories
11.8.2. Clinical Laboratories
11.8.3. Academic and Research Institutes
11.8.4. Pharmaceutical and Biotechnology Companies
11.9. Market Attractiveness Analysis
11.10. Market Share Analysis, 2023
11.11. Market Structure
11.11.1. Competition Intensity Mapping By Market
11.11.2. Competition Dashboard
11.12. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.12.1. Creative BioLabs
11.12.1.1. Overview
11.12.1.2. Segments and Platforms Types
11.12.1.3. Key Financials
11.12.1.4. Market Developments
11.12.1.5. Market Strategy
11.12.2. Synbio Technologies
11.12.3. GenScript Biotech Corporation
11.12.4. ProSci Incorporated
11.12.5. BioCat GmbH
11.12.6. Antibody Design Labs
11.12.7. Rockland Immunochemicals, Inc.
11.12.8. Hybrigenics Services
11.12.9. NeoClone Biotechnology International LLC
11.12.10. Kaneka Eurogentec S.A
11.12.11. ProteoGenix
11.12.12. Others
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations